Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Restructuring Costs: 2020-2024

Historic Restructuring Costs for Aytu Biopharma (AYTU) over the last 1 years, with Dec 2024 value amounting to $1.3 million.

  • Aytu Biopharma's Restructuring Costs was N/A to $1.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.3 million, marking a year-over-year change of. This contributed to the annual value of $2.1 million for FY2025, which is 2.55% down from last year.
  • As of Q4 2024, Aytu Biopharma's Restructuring Costs stood at $1.3 million, which was up 67.98% from $784,000 recorded in Q3 2024.
  • Aytu Biopharma's Restructuring Costs' 5-year high stood at $4.8 million during Q1 2021, with a 5-year trough of $11,000 in Q2 2021.
  • For the 1-year period, Aytu Biopharma's Restructuring Costs averaged around $1.1 million, with its median value being $1.1 million (2024).
  • Data for Aytu Biopharma's Restructuring Costs shows a peak YoY increase of 1,448.78% (in 2021) and a maximum YoY decrease of 98.65% (in 2021) over the last 5 years.
  • Over the past 3 years, Aytu Biopharma's Restructuring Costs (Quarterly) stood at $814,277 in 2020, then plummeted by 98.65% to $11,000 in 2021, then reached $1.3 million in 2024.
  • Its last three reported values are $1.3 million in Q4 2024, $784,000 for Q3 2024, and $1.9 million during Q2 2024.